Skip to main content
. 2024 Jun 29;4:102856. doi: 10.1016/j.bas.2024.102856

Table 2.

Literature review of the main previously reported case series (>3 cases) on lateral transorbital endoscopic approach.

Author, Year PMID # of Patients Type of Tumors Orbital Space Involvement
# of lesions w/Intradural Involvement Extent of Resection (#/%)
Complication Rate (#/%) Type of Complications Average Follow-up (months)
Extraconal Intraconal GTR/NTR STR
Kong et al., 2018 (Kong et al., 2018) 30215555 17 12 Meningiomas
1 Sebaceous gland carcinoma
1 Cystic teratoma
1 Intraconal Schwannoma
1 Osteosarcoma
1 Plasmacytoma
16 1 13 13 (76.4 %) 4 (25.5 %) 2 (11.1 %) Periorbital swelling 5.3 ± 3.7
Dallan et al., 2018 (Dallan et al., 2018) 29462449 14 Spheno-orbital Meningioma 8 3 3 5 (35.7 %) 9 (64.3 %) 10 (71.43%) Necrosis of the upper eyelid, diplopia, V1 hypoesthesia, V2 hypoesthesia, left periorbital emphysema, palpebral edema 25
Jeon et al., 2018 (Jeon et al., 2018) 30544350 9 4 Trigeminal Schwannomas
2 Meningiomas
1 Chondrosarcoma
1 Metastatic lesion
1 Dermoid cyst
NA NA 6 7 (77.8 %) 2 (22.2 %) 1 (11%) Ptosis NA
Park et al., 2020 (Park et al., 2020) 31226689 25 Trigeminal Schwannomas 17 19 (76 %) 6 (24 %) 3 (12 %) Middle cerebral artery vasospasm, infection, medial gaze palsy NA
Locatelli et al., 2020 (Locatelli et al., 2020) 35433179 18 18 meningioma 18 8 14 7 (38,9%) 11 (61,1%) 3 (16,7%) 1 visual deficit, 2 trigeminal hypoesthesia 31.5 (6–84)
Kong et al., 2020 (Sakashita et al., 2009) 32502989 41 39 grade I and 2 grade 2 meningiomas NA NA 41 21 (51,2%) 20 (48,8%) 4 (9,8%) 2 CSF leak, 2 wound complications 16
In Woo et al. (2021) (Dallan et al., 2018) 33226438 18 17 meningioma grade I, 1 meningioma grade II 18 8 10 3 (16,7%) 15 (83,3%) 8 (44%) 3 transient EOM deficit, 3 trigeminal hypoesthesia, 1 CSF leak, 1 wound infection 20 ± 10
Di Somma et al., 2023 (Locatelli et al., 2020) 37410915 20 5 spheno-orbital meningiomas, 1 intradiploic Meningioma, 2 intraconal lesions, 1 temporal pole lesion, 2 trigeminal schwannoma, 3 cavernous sinus lesions, and 6 petroclival lesions 5 2 12 NA NA 4 (20%) 1 limitation of eye abduction, 1 ocular neuropathic pain, 2 slight enophthalmus NA
Han X et al., 2023 (Di Somma et al., 2023) 36947242 16 8 meningiomas, 2 hemangiomas, 1 low-grade glioma, 1 instance of inflammatory hyperplasia tissue, 1 Langerhans cell histiocytosis, 1 epidermoid cyst, 1 trigeminal schwannoma, and 1 bone fibrosis hyperplasia 6 7 3 13 (81,3%) 0 (0%) NA
Zoli et al., 2023 (Zoli et al., 2023) 37331478 22 16 meningioma grade I, 3 meningioma grade II, 1 fibrousdysplasia, 1 Plasmocytoma, 1 solitary fibrous tumor 22 12 18 8 (36.4%) 14 (63.4%) 5 (22,7%) 1 CSDH,1 permanent EOM deficit,3 trigeminal hypoesthesia 46 (6–90)
Present study 38 12 meningiomas, 8 cavernous haemangioma, 5 metastasis, 4 dermoid cysts, 1 lymphoma, 1 fibromyxoid sarcoma, 2 inflammatory lesion, 1 mastocytosis, 1 mucocele, 1 mucoepidermoid carcinoma, 1 schwannoma, 1 venous varix 12 20 7 29/35 (82,9%) 6/35 (17,1%) 8/38 (21%) 1 orbital abscess, 2 transient ptosis, 2 transient diplopia, 1 transient facial palsy, 1 transient III nerve palsy, 1 transient supraorbital neuralgia 40,9 ± 24,8

NA: data not available; GTR: gross total removal; NTR: near total removal; STR: subtotal removal.